Optical fiber-based in vivo quantification of growth factor receptors

作者: Thommey P. Thomas , Yu-Chung Chang , Jing Yong Ye , Alina Kotlyar , Zhengyi Cao

DOI: 10.1002/CNCR.26487

关键词:

摘要: BACKGROUND: Growth factor receptors such as epidermal growth receptor 1 and human 2 (HER2) are overexpressed in certain cancer cells. Antibodies against these (eg. cetuximab transtuzumab [Herceptin]) have shown therapeutic value treatment. The existing methods for the quantification of tumors involve immunohistochemistry or DNA quantification, both extracted tissue samples. goal study was to evaluate whether an optical fiber-based technique can be used quantify expression multiple simultaneously. METHODS: The authors examined HER2 using monoclonal antibody trastuzumab a targeting ligand test their system. They conjugated different Alexa Fluor dyes with excitation emission wavelengths. Two dye conjugates were subsequently injected intravenously into mice bearing HER2-expressing subcutaneous tumors. An fiber then inserted tumor through 30-gauge needle, single laser beam source, fluorescence emitted by identified quantified 2-photon fluorescence. RESULTS: The bound competitively receptor-specific fashion, but they failed bind similar cell that did not express HER2. concentration conjugate present determined serve index levels. CONCLUSIONS: These studies offer minimally invasive simultaneously. Cancer 2012;. © 2011 American Society.

参考文章(57)
, Etta D. Pisano, Laurie L. Fajardo, John Tsimikas, Nour Sneige, William J. Frable, Constantine A. Gatsonis, W. Phil Evans, Irena Tocino, Barbara J. McNeil, Rate of insufficient samples for fine-needle aspiration for nonpalpable breast lesions in a multicenter clinical trial: The Radiologic Diagnostic Oncology Group 5 study Cancer. ,vol. 82, pp. 679- 688 ,(1998) , 10.1002/(SICI)1097-0142(19980215)82:4<679::AID-CNCR10>3.0.CO;2-V
Kolja Freier, Carsten Schwaenen, Carsten Sticht, Christa Flechtenmacher, Joachim Mühling, Christof Hofele, Bernhard Radlwimmer, Peter Lichter, Stefan Joos, Recurrent FGFR1 amplification and high FGFR1 protein expression in oral squamous cell carcinoma (OSCC). Oral Oncology. ,vol. 43, pp. 60- 66 ,(2007) , 10.1016/J.ORALONCOLOGY.2006.01.005
Robin L Jones, Ian E Smith, Efficacy and safety of trastuzumab. Expert Opinion on Drug Safety. ,vol. 3, pp. 317- 327 ,(2004) , 10.1517/14740338.3.4.317
Nicholas Turner, Richard Grose, Fibroblast growth factor signalling: from development to cancer. Nature Reviews Cancer. ,vol. 10, pp. 116- 129 ,(2010) , 10.1038/NRC2780
Robert Roskoski, The ErbB/HER receptor protein-tyrosine kinases and cancer. Biochemical and Biophysical Research Communications. ,vol. 319, pp. 1- 11 ,(2004) , 10.1016/J.BBRC.2004.04.150
Thommey P. Thomas, Jing Yong Ye, Yu-Chung Chang, Alina Kotlyar, Zhengyi Cao, Istvan J. Majoros, Theodore B. Norris, James R. Baker, Investigation of tumor cell targeting of a dendrimer nanoparticle using a double-clad optical fiber probe. Journal of Biomedical Optics. ,vol. 13, pp. 014024- ,(2008) , 10.1117/1.2870105
Fernando Schmitt, HER2+ breast cancer: How to evaluate? Advances in Therapy. ,vol. 26, pp. 1- 8 ,(2009) , 10.1007/S12325-009-0046-1
Shanchun Guo, Laronna S. Colbert, Miles Fuller, Yuanyuan Zhang, Ruben R. Gonzalez-Perez, Vascular Endothelial Growth Factor Receptor -2 in Breast Cancer Biochimica et Biophysica Acta. ,vol. 1806, pp. 108- 121 ,(2010) , 10.1016/J.BBCAN.2010.04.004